GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
20.25
+1.44 (7.66%)
At close: Apr 24, 2026, 4:00 PM EDT
20.64
+0.39 (1.93%)
After-hours: Apr 24, 2026, 7:57 PM EDT
GH Research Earnings Call Transcripts
Fiscal Year 2025
-
GH001 showed rapid, robust, and sustained efficacy in TRD, with a high remission rate and favorable safety profile. Long-term data indicate durable remission with infrequent treatments and fewer clinic visits compared to current standards.